These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15801011)

  • 1. Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis.
    Wolfe F; Michaud K; Strand V
    J Rheumatol; 2005 Apr; 32(4):583-9. PubMed ID: 15801011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
    Strand V; Scott DL; Emery P; Kalden JR; Smolen JS; Cannon GW; Tugwell P; Crawford B;
    J Rheumatol; 2005 Apr; 32(4):590-601. PubMed ID: 15801012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What factors influence the health status of patients with rheumatoid arthritis measured by the SF-12v2 Health Survey and the Health Assessment Questionnaire?
    Linde L; Sørensen J; Østergaard M; Hørslev-Petersen K; Rasmussen C; Jensen DV; Hetland ML
    J Rheumatol; 2009 Oct; 36(10):2183-9. PubMed ID: 19723897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM; Fransen J; van Riel PL
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.
    Pope JE; Khanna D; Norrie D; Ouimet JM
    J Rheumatol; 2009 Feb; 36(2):254-9. PubMed ID: 19132791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia.
    Wolfe F; Michaud K
    J Rheumatol; 2004 Apr; 31(4):695-700. PubMed ID: 15088293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Rasch analysis to compare the psychometric properties of the Short Form 36 physical function score and the Health Assessment Questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis.
    Taylor WJ; McPherson KM
    Arthritis Rheum; 2007 Jun; 57(5):723-9. PubMed ID: 17530670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining rheumatologists' accuracy at assessing functional disability in rheumatoid arthritis patients using the Health Assessment Questionnaire-Disability Index.
    Carter JD; Lodhi AB; Nagda SR; Ricca L; Ward C; Traina E; Thompson ZJ; Huang Y; Valeriano J; Vasey FB
    J Rheumatol; 2007 May; 34(5):958-63. PubMed ID: 17407221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis.
    Wells G; Li T; Maxwell L; MacLean R; Tugwell P
    J Rheumatol; 2007 Feb; 34(2):280-9. PubMed ID: 17304654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients.
    Walker N; Michaud K; Wolfe F
    J Rheumatol; 2005 Jun; 32(6):1006-12. PubMed ID: 15940759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population.
    Sokka T; Kautiainen H; Hannonen P; Pincus T
    Arthritis Rheum; 2006 Oct; 54(10):3113-8. PubMed ID: 17009231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of standard and alternative health assessment questionnaire scoring procedures for documenting functional outcomes in patients with rheumatoid arthritis.
    Tomlin GS; Holm MB; Rogers JC; Kwoh CK
    J Rheumatol; 1996 Sep; 23(9):1524-30. PubMed ID: 8877919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.
    Ranzolin A; Brenol JC; Bredemeier M; Guarienti J; Rizzatti M; Feldman D; Xavier RM
    Arthritis Rheum; 2009 Jun; 61(6):794-800. PubMed ID: 19479706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee.
    Goldsmith CH; Boers M; Bombardier C; Tugwell P
    J Rheumatol; 1993 Mar; 20(3):561-5. PubMed ID: 8478874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
    Mease PJ; Revicki DA; Szechinski J; Greenwald M; Kivitz A; Barile-Fabris L; Kalsi J; Eames J; Leirisalo-Repo M
    J Rheumatol; 2008 Jan; 35(1):20-30. PubMed ID: 18050385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and pain scales.
    Copay AG; Glassman SD; Subach BR; Berven S; Schuler TC; Carreon LY
    Spine J; 2008; 8(6):968-74. PubMed ID: 18201937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed metrics for the determination of rheumatoid arthritis outcome and treatment success and failure.
    Wolfe F; Michaud K
    J Rheumatol; 2009 Jan; 36(1):27-33. PubMed ID: 19040313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.
    Farahani P; Levine M; Gaebel K; Thabane L
    Can J Clin Pharmacol; 2005; 12(3):e254-63. PubMed ID: 16278497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis.
    Michaud K; Vera-Llonch M; Oster G
    J Rheumatol; 2012 Jan; 39(1):54-9. PubMed ID: 22089466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.